DeFloria’s advances cannabis-based autism drug through early trial

The joint venture between Charlotte’s Web and British American Tobacco plans to launch two Phase 2 trials in the second quarter of 2025.

The post DeFloria’s advances cannabis-based autism drug through early trial appeared first on Green Market Report.